keyword
https://read.qxmd.com/read/38584541/recent-advancements-in-refashioning-of-nsaids-and-their-derivatives-as-anticancer-candidates
#1
JOURNAL ARTICLE
Asmaa E Kassab, Ehab M Gedawy
Inflammation is critical to the formation and development of tumors and is closely associated with cancer. Therefore, addressing inflammation and the mediators that contribute to the inflammatory process may be a useful strategy for both cancer prevention and treatment. Tumor predisposition can be attributed to inflammation. It has been demonstrated that NSAIDs can modify the tumor microenvironment by enhancing apoptosis and chemosensitivity and reducing cell migration. There has been a recent rise in interest in drug repositioning or repurposing because the development of innovative medications is expensive, timeconsuming, and presents a considerable obstacle to drug discovery...
April 5, 2024: Current Pharmaceutical Design
https://read.qxmd.com/read/38503889/ethno-entomotherapeutic-and-metabolite-profiling-of-coridius-chinensis-dallas-a-traditional-edible-insect-species-of-north-east-india
#2
JOURNAL ARTICLE
Rajkumari Bonysana, Kabrambam Dasanta Singh, Wahengbam Deepanita Devi, Arunkumar Singh Koijam, Kokho Kapesa, Jatin Kalita, Pulok Kumar Mukherjee, Yallappa Rajashekar
Edible insects possess several health enhancing properties and play an important role in human nutrition. Coridius chinensis is an edible insect that is considered food and claimed as traditional medicine. In the present study, nutritional contents, chemical composition, antioxidant, and anti-inflammatory properties of C. chinensis were analyzed. It was found that the insect sample contains 50.46% moisture, 44.65% protein, 4.45% carbohydrate, 39.42% crude fats, 3.53% ash and 576.11 (Kcal/100 g) energy...
March 19, 2024: Scientific Reports
https://read.qxmd.com/read/38451034/drug-induced-liver-injury-dili-ascribed-to-non-steroidal-anti-inflammatory-drugs-nsaids-in-the-usa-update-with-genetic-correlations
#3
JOURNAL ARTICLE
Herbert L Bonkovsky, Marwan Ghabril, Paola Nicoletti, Andrew Dellinger, Robert J Fontana, Huiman Barnhart, Jiezhun Gu, Ann K Daly, Guruprasad P Aithal, Elizabeth J Phillips, David E Kleiner
OBJECTIVE: To describe patients with NSAID-DILI, including genetic factors associated with idiosyncratic DILI. METHODS: In DILIN, subjects with presumed DILI are enrolled and followed for at least 6 months. Causality is adjudicated by a Delphic approach. HLA sequencing of multiethnic NSAID-DILI patients and HLA allele imputation of matching population controls were performed following overall, class and drug-based association analysis. Significant results were tested in a non-Hispanic White (NHW) case-control replication cohort...
March 7, 2024: Liver International: Official Journal of the International Association for the Study of the Liver
https://read.qxmd.com/read/38394820/a-systematic-study-of-the-effect-of-lipid-architecture-on-cytotoxicity-and-cellular-uptake-of-cationic-cubosomes
#4
JOURNAL ARTICLE
S Pushpa Ragini, Brendan P Dyett, Sampa Sarkar, Jiali Zhai, Jacinta F White, Rajkumar Banerjee, Calum J Drummond, Charlotte E Conn
HYPOTHESIS: Lipid nanoparticles containing a cationic lipid are increasingly used in drug and gene delivery as they can display improved cellular uptake, enhanced loading for anionic cargo such as siRNA and mRNA or exhibit additional functionality such as cytotoxicity against cancer cells. This research study tests the hypothesis that the molecular structure of the cationic lipid influences the structure of the lipid nanoparticle, the cellular uptake, and the resultant cytotoxicity. EXPERIMENTS: Three potentially cytotoxic cationic lipids, with systematic variations to the hydrophobic moiety, were designed and synthesised...
February 15, 2024: Journal of Colloid and Interface Science
https://read.qxmd.com/read/38160288/modeling-path-importance-for-effective-alzheimer-s-disease-drug-repurposing
#5
JOURNAL ARTICLE
Shunian Xiang, Patrick J Lawrence, Bo Peng, ChienWei Chiang, Dokyoon Kim, Li Shen, Xia Ning
Recently, drug repurposing has emerged as an effective and resource-efficient paradigm for AD drug discovery. Among various methods for drug repurposing, network-based methods have shown promising results as they are capable of leveraging complex networks that integrate multiple interaction types, such as protein-protein interactions, to more effectively identify candidate drugs. However, existing approaches typically assume paths of the same length in the network have equal importance in identifying the therapeutic effect of drugs...
2024: Pacific Symposium on Biocomputing
https://read.qxmd.com/read/38101302/preparation-of-chiral-monoliths-with-new-modulation-of-the-monolith-surface-chemistry-for-the-enantioseparation-of-chiral-drugs-by-nano-liquid-chromatography
#6
JOURNAL ARTICLE
Sinan Bayındır, Cemil Aydoğan, Adil Denizli
Here, we report the preparation and application of two new chiral monoliths for the enantioseparation of chiral drugs in nano-LC. Using 3‑chloro-2-hydroxypropylmethacrylate (HPMA-Cl, 2) as a precursor monomer, two different chiral monomers namely, Nα -Boc-Lys-HPMA (3A) and Nα -Fmoc-Lys-HPMA (3B) were synthesized and used for the preparation of chiral polymer monoliths. The first monolithic column (referred to as monolith I) was prepared by an in-situ polymerization of Nα -Boc-Lys-HPMA as the chiral monomer and ethylene dimethacrylate while the second monolithic column (referred to as monolith II) was prepared by an in-situ polymerization of Nα -Fmoc-Lys-HPMA as the chiral monomer and ethylene dimethacrylate as the crosslinker...
December 9, 2023: Journal of Chromatography. A
https://read.qxmd.com/read/38066008/exploring-the-therapeutic-potential-of-sodium-deoxycholate-tailored-deformable-emulsomes-of-etodolac-for-effective-management-of-arthritis
#7
JOURNAL ARTICLE
Gajanand Sharma, Akanksha Mahajan, Kanika Thakur, Gurjeet Kaur, Vijay G Goni, Muniramiah Vinod Kumar, Ravi Pratap Barnwal, Gurpal Singh, Bhupinder Singh, O P Katare
The current piece of research intends to evaluate the potential of combining etodolac with deformable-emulsomes, a flexible vesicular system, as a promising strategy for the topical therapy of arthritis. The developed carrier system featured nanometric dimensions (102 nm), an improved zeta potential (- 5.05 mV), sustained drug release (31.33%), and enhanced drug deposition (33.13%) of DE-gel vis-à-vis conventional system (10.34% and 14.71%). The amount of permeation of the developed nano formulation across skin layers was demonstrated through CLSM and dermatokinetics studies...
December 7, 2023: Scientific Reports
https://read.qxmd.com/read/37961739/modeling-path-importance-for-effective-alzheimer-s-disease-drug-repurposing
#8
Shunian Xiang, Patrick J Lawrence, Bo Peng, ChienWei Chiang, Dokyoon Kim, Li Shen, Xia Ning
Recently, drug repurposing has emerged as an effective and resource-efficient paradigm for AD drug discovery. Among various methods for drug repurposing, network-based methods have shown promising results as they are capable of leveraging complex networks that integrate multiple interaction types, such as protein-protein interactions, to more effectively identify candidate drugs. However, existing approaches typically assume paths of the same length in the network have equal importance in identifying the therapeutic effect of drugs...
October 27, 2023: ArXiv
https://read.qxmd.com/read/37896270/nanoemulsions-as-a-promising-carrier-for-topical-delivery-of-etodolac-formulation-development-and-characterization
#9
JOURNAL ARTICLE
Samet Özdemir, Burcu Üner, Alptuğ Karaküçük, Burak Çelik, Engin Sümer, Çetin Taş
This research primarily focuses on the development of innovative topical nanoemulsions for etodolac, aimed at surmounting its inherent limitations. The preparation of etodolac nanoemulsions is accomplished through a combination of high shear homogenization and ultrasonication methods. The optimization of the formulation components is systematically conducted using the design of experiments methodology. The droplet size (DS), polydispersity index (PDI), and zeta potential (ZP) of the optimized formulation were assessed using the differential light scattering (DLS) technique...
October 23, 2023: Pharmaceutics
https://read.qxmd.com/read/37633536/selective-cox-2-inhibitors-after-bariatric-surgery-celecoxib-etoricoxib-and-etodolac-post-bariatric-solubility-dissolution-and-pharmacokinetics
#10
JOURNAL ARTICLE
Daniel Porat, Oleg Dukhno, Mazal Partook-Maccabi, Ella Vainer, Sandra Cvijić, Arik Dahan
Anatomical/physiological gastrointestinal changes after bariatric surgery may influence the fate of orally administered drugs.Since non-selective NSAIDs are not well-tolerated post-surgery, selective cyclooxygenase-2 (COX-2) inhibitors may be important for these patients. In this work we investigated celecoxib, etoricoxib and etodolac, for impaired post-bariatric solubility/dissolution and absorption. Solubility was studied in-vitro, and ex-vivoin aspirated gastric contents from patients pre- vs. post-surgery...
August 24, 2023: International Journal of Pharmaceutics
https://read.qxmd.com/read/37619960/chemoprophylaxis-for-heterotrophic-ossification-following-hip-arthroscopy-a-systematic-review
#11
REVIEW
Robert S Dean, Britanny A Hamama, Leonardo Cavinatto, Shane J Nho, Jorge Chahla, Betina B Hinckel
INTRODUCTION: Heterotrophic ossification (HO) is a known complication diagnosed following hip arthroscopy. PURPOSE/HYPOTHESIS: This study sought to review the current literature on chemoprophylaxis for HO following hip arthroscopy and to describe what agents and doses are being utilized. STUDY DESIGN: Systematic Review. METHODS: A systematic review was performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines on the use of chemoprophylactic medications for HO prevention following hip arthroscopy...
August 22, 2023: Journal of ISAKOS
https://read.qxmd.com/read/37499995/effects-of-acidic-non-steroidal-anti-inflammatory-drugs-on-human-cytochrome-p450-4a11-activity-roles-of-carboxylic-acid-and-a-sulfur-atom-in-potent-inhibition-by-sulindac-sulfide
#12
JOURNAL ARTICLE
Hisataka Itoh, Naho Yamashita, Shinobu Kamijo, Kazufumi Masuda, Hisato Kato, Satoshi Yamaori
Cytochrome P450 4A11 (CYP4A11) has many endogenous and exogenous compounds containing a carboxyl group in their structure as substrates. If drugs with this characteristic potently attenuate the catalytic function of CYP4A11, drug-drug interactions may occur. Acidic non-steroidal anti-inflammatory drugs (NSAIDs) possess a carboxylic acid in their structure. However, it remains unclear whether these drugs inhibit CYP4A11 activity. The present study examined the inhibitory effects of acidic NSAIDs on CYP4A11 activity using human liver microsomes (HLMs) and recombinant CYP4A11...
July 25, 2023: Chemico-biological Interactions
https://read.qxmd.com/read/37385823/cardiovascular-risks-of-continuing-vs-initiating-nsaids-after-first-time-myocardial-infarction-or-heart-failure-a-nationwide-cohort-study
#13
JOURNAL ARTICLE
Morten Schmidt, Jesper Hallas, Martin Thomsen Ernst, Anton Pottegård
AIMS: It is unknown whether the cardiovascular risks associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) shortly after first-time myocardial infarction (MI) or heart failure (HF) differ between patients continuing and initiating use. METHODS AND RESULTS: Using nationwide health registries, we conducted a cohort study of all patients with first-time MI or HF during 1996-2018 (n = 273 682). NSAID users (n = 97 966) were categorized as continuing (17%) and initiating (83%) users according to prescription fillings < 60 days before index diagnosis...
June 29, 2023: European Heart Journal. Cardiovascular Pharmacotherapy
https://read.qxmd.com/read/37296934/drug-repurposing-in-oncology-a-systematic-review-of-randomized-controlled-clinical-trials
#14
REVIEW
Ignatios Ioakeim-Skoufa, Natalia Tobajas-Ramos, Enrica Menditto, Mercedes Aza-Pascual-Salcedo, Antonio Gimeno-Miguel, Valentina Orlando, Francisca González-Rubio, Ana Fanlo-Villacampa, Carmen Lasala-Aza, Ewelina Ostasz, Jorge Vicente-Romero
Quality pharmacological treatment can improve survival in many types of cancer. Drug repurposing offers advantages in comparison with traditional drug development procedures, reducing time and risk. This systematic review identified the most recent randomized controlled clinical trials that focus on drug repurposing in oncology. We found that only a few clinical trials were placebo-controlled or standard-of-care-alone-controlled. Metformin has been studied for potential use in various types of cancer, including prostate, lung, and pancreatic cancer...
May 30, 2023: Cancers
https://read.qxmd.com/read/37127226/-don-t-let-it-to-air-a-cautionary-tale-of-the-potential-consequences-of-surgery-of-residual-cancer
#15
JOURNAL ARTICLE
Gayashan Tennakoon, Rebecca Auer
In this issue of the BBI, Haldar et al. demonstrate that major surgical stress from laparotomy caused a significant increase in post-operative metastatic burden in a mouse model of cancer. They identified this metastatic outbreak was driven by a novel mechanism of direct, surgery-induced activation of the primary tumour which, if left in situ, released pro-metastatic factors (IL-6, IL-8, and VEGF). Surgical stress induced significant changes in the transcriptional programming of the primary tumor, with marked activation of NF-κB and down-regulation of IRF-1...
April 29, 2023: Brain, Behavior, and Immunity
https://read.qxmd.com/read/37030108/towards-the-development-of-dual-hypouricemic-and-anti-inflammatory-candidates-design-synthesis-stability-studies-and-biological-evaluation-of-some-mutual-ester-prodrugs-of-febuxostat-nsaids
#16
JOURNAL ARTICLE
Aya Y Rashad, Hoda G Daabees, Mohamed Elagawany, Mohamed Shahin, Ahmed E Abdel Moneim, Sherif A F Rostom
Treatment of gout involves two basic approaches: reducing the serum uric acid mainly by xanthine oxidase inhibitors (XOIs) and alleviating the intensity of the accompanying acute arthritic inflammation using non-steroidal anti-inflammatory drugs (NSAIDs). Febuxostat (FEB) is the first non-purine XOI approved for the treatment of hyperuricemia and gout. The present study aims at combining the hypouricemic effect of FEB and the anti-inflammatory (AI) properties of NSAIDs in a single entity by adopting the "mutual prodrug" approach...
March 31, 2023: Bioorganic Chemistry
https://read.qxmd.com/read/36972286/does-etodolac-affect-trpa1-functionality-in%C3%A2-vivo-in-human
#17
JOURNAL ARTICLE
Heleen Marynissen, Delphine Mergaerts, Dorien Bamps, Jan de Hoon
OBJECTIVES: In preclinical research, etodolac, a non-steroidal anti-inflammatory drug, affected transient receptor potential ankyrin 1 (TRPA1) activation. Yet, whether the in vitro interaction between etodolac and TRPA1 translates to altered TRPA1 functionality in vivo in human remains to be investigated. METHODS: A randomized, double-blinded, celecoxib-controlled study was conducted to assess the effect of etodolac on TRPA1-mediated dermal blood flow (DBF) changes on the forearm of 15 healthy, male volunteers aged between 18 and 45 years...
March 27, 2023: Journal of Basic and Clinical Physiology and Pharmacology
https://read.qxmd.com/read/36959150/interactions-of-cyclodextrins-and-their-hydroxyl-derivatives-with-etodolac-solubility-and-dissolution-enhancement
#18
JOURNAL ARTICLE
Wesam W Mustafa, Mouhamad Khoder, Hamdy Abdelkader, Richard Singer, Raid Alany
BACKGROUND: Poor solubility and dissolution rate of drugs are largely responsible for erratic drug absorption and limited oral bioavailability. Etodolac (ETO) is a non-steroidal anti-inflammatory drug (NSAID) that is classified as BCS class II (dissolution rate-dependent absorption). ETO has high safety and efficacy in pain relief and control of inflammation. ETO is commercially available as (400-600 mg) tablets; poor solubility and dissolution rate of ETO could result in variable oral absorption and inconsistent analgesic responses...
March 20, 2023: Current Drug Delivery
https://read.qxmd.com/read/36792039/disconnect-between-cox-2-selective-inhibition-and-cardiovascular-risk-in-preclinical-models
#19
JOURNAL ARTICLE
Yevgeniya E Koshman, Aimee L Bielinski, Brandan M Bird, Jonathon R Green, Kenneth L Kowalkowski, Jie Lai-Zhang, Prathap Kumar Mahalingaiah, James W Sawicki, Nari N Talaty, Amanda S Wilsey, Mark T Zafiratos, Terry R Van Vleet
INTRODUCTION: Secondary pharmacology profiling is routinely applied in pharmaceutical drug discovery to investigate the pharmaceutical effects of a drug at molecular targets distinct from (off-target) the intended therapeutic molecular target (on-target). Data from a randomized, placebo-controlled clinical trial, the APPROVe (Adenomatous Polyp Prevention on VIOXX, rofecoxib) trial, raised significant concerns about COX-2 inhibition as a primary or secondary target, shaping the screening and decision-making processes of some pharmaceutical companies...
February 13, 2023: Journal of Pharmacological and Toxicological Methods
https://read.qxmd.com/read/36646396/perioperative-escape-from-dormancy-of-spontaneous-micro-metastases-a-role-for-malignant-secretion-of-il-6-il-8-and-vegf-through-adrenergic-and-prostaglandin-signaling
#20
JOURNAL ARTICLE
Rita Haldar, Lee Shaashua Berger, Ella Rossenne, Arielle Radin, Anabel Eckerling, Elad Sandbank, Erica K Sloan, Steve W Cole, Shamgar Ben-Eliyahu
We recently showed that a minimally-invasive removal of MDA-MB-231HM primary tumors (PTs) and elimination of their secreted factors (including IL-6, IL-8, VEGF, EGF, PDGF-aa, MIF, SerpinE1, and M-CSF), caused regression of spontaneous micro-metastases into a non-growing dormant state. To explore the underlying mechanisms and potential clinical ramifications of this phenomenon, we herein used the MDA-MB-231HM human breast cancer cell-line, in-vitro, and in vivo following orthotopic implantation in immune-deficient BALB/C nu/nu mice...
January 13, 2023: Brain, Behavior, and Immunity
keyword
keyword
114793
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.